1. Glycosylation signature of plasma IgA of critically ill COVID-19 patients.
- Author
-
Potaczek DP, van Tol BDM, Falck D, Krolczik C, Zlatina K, Bertrams W, Wilhelm J, Schmeck B, Seeliger B, David S, Skevaki C, Mack E, Seeger W, Schaefer L, Galuska SP, Wuhrer M, and Wygrecka M
- Subjects
- Humans, Glycosylation, Middle Aged, Male, Female, Aged, Adult, Influenza, Human immunology, Influenza, Human blood, Respiratory Distress Syndrome immunology, Respiratory Distress Syndrome blood, COVID-19 immunology, COVID-19 blood, Immunoglobulin A blood, Immunoglobulin A immunology, Critical Illness, SARS-CoV-2 immunology, Polysaccharides immunology, Polysaccharides blood
- Abstract
Thromboembolic complications are common in severe COVID-19 and are thought to result from excessive neutrophil-extracellular-trap (NET)-driven immunothrombosis. Glycosylation plays a vital role in the efficiency of immunoglobulin A (IgA) effector functions, with significant implications for NET formation in infectious diseases. This study represents the first comprehensive analysis of plasma IgA glycosylation during severe SARS-CoV-2 or Influenza A infection, revealing lower sialylation and higher galactosylation of IgA1 O-glycans in acute respiratory distress syndrome (ARDS), regardless of the underlying cause of the disease. Importantly, N-glycans displayed an infection-specific pattern, with N47 of IgA2 showing diminished sialylation and bisection, and N340/N327 of IgA1/2 demonstrating lower fucosylation and antennarity along with higher non-complex glycans in COVID-19 compared to Influenza. Notably, COVID-19 IgA possessed strong ability to induce NET formation and its glycosylation patterns correlated with extracellular DNA levels in plasma of critically ill COVID-19 patients. Our data underscores the necessity of further research on the role of IgA glycosylation in the modulation of pathogen-specific immune responses in COVID-19 and other infectious diseases., Competing Interests: Author DP is employee of Bioscientia MVZ Labor Mittelhessen GmbH, Giessen, Germany. DP employment at Bioscientia MVZ Labor Mittelhessen is not related to and has not affected in any way the content of this article. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Potaczek, van Tol, Falck, Krolczik, Zlatina, Bertrams, Wilhelm, Schmeck, Seeliger, David, Skevaki, Mack, Seeger, Schaefer, Galuska, Wuhrer and Wygrecka.)
- Published
- 2024
- Full Text
- View/download PDF